Enhancing Catalytic Activity of a Nickel Single Atom Enzyme by Polynary Heteroatom Doping for Ferroptosis-Based Tumor Therapy

ACS Nano. 2023 Feb 14;17(3):3064-3076. doi: 10.1021/acsnano.2c11923. Epub 2023 Jan 16.

Abstract

As a rising generation of nanozymes, single atom enzymes show significant promise for cancer therapy, due to their maximum atom utilization efficiency and well-defined electronic structures. However, it remains a tremendous challenge to precisely produce a heteroatom-doped single atom enzyme with an expected coordination environment. Herein, we develop an anion exchange strategy for precisely controlled production of an edge-rich sulfur (S)- and nitrogen (N)-decorated nickel single atom enzyme (S-N/Ni PSAE). In particular, sulfurized S-N/Ni PSAE exhibits stronger peroxidase-like and glutathione oxidase-like activities than the nitrogen-monodoped nickel single atom enzyme, which is attributed to the vacancies and defective sites of sulfurized nitrogen atoms. Moreover, both in vitro and in vivo results demonstrate that, compared with nitrogen-monodoped N/Ni PSAE, sulfurized S-N/Ni PSAE more effectively triggers ferroptosis of tumor cells via inactivating glutathione peroxidase 4 and inducing lipid peroxidation. This study highlights the enhanced catalytic efficacy of a polynary heteroatom-doped single atom enzyme for ferroptosis-based cancer therapy.

Keywords: ferroptosis; heteroatom doping; lipid peroxidation; single atom enzyme; tumor therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ferroptosis*
  • Humans
  • Neoplasms* / drug therapy
  • Nickel
  • Nitrogen
  • Peroxidase

Substances

  • Nickel
  • Peroxidase
  • Nitrogen